Canada Clears Abbott HPV Molecular Diagnostic Test – GenomeWeb

Canada Clears Abbott HPV Molecular Diagnostic Test
GenomeWeb
NEW YORK (GenomeWeb News) – The Medical Device Bureau of Health Canada has granted a license to Abbott to market its RealTime High Risk HPV molecular diagnostic test for detecting human papillomavirus, Abbott announced today. The test, which
Abbott Introduces its RealTime Molecular Test for Human Papillomavirus (HPV Wall Street Journal (press release)

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *